2m 2m 2m 2m 2m 2m 2m
Hyperfine-A (HYPR)
NASDAQ
$1.48-$0.01 (-0.67%)
Price as of Jun 03, 2026 6:09 PM EDT- $131.4MMarket Cap
- 102.81%1-Year Change
- Medical DevicesIndustry
Hyperfine-A (HYPR)
$1.48-$0.01 (-0.67%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 11.4M -11.57% | 12.9M +16.84% | 11.0M N/A | N/A N/A | |
Cost of Revenue | 5.8M -17.77% | 7.0M +11.54% | 6.3M +6.23% | 5.9M +121.82% | |
Gross Profit | 6.8M +14.63% | 5.9M +23.84% | 4.8M +424.48% | 907,000 +177.72% | |
Sales and Marketing Expense | 10.1M +11.09% | 9.1M -9.71% | 10.1M -28.95% | 14.2M +37.22% | |
Research and Development Expense | -17.5M -22.44% | -22.5M +0.03% | -22.5M -20.11% | -28.2M +8.95% | |
Depreciation and Amortization Expense | 1.1M +8.03% | 1.0M -4.27% | 1.1M +3.84% | 1.0M +39.81% | |
Total Operating Expenses | 43.8M -10.74% | 49.1M -7.11% | 52.9M -29.30% | 74.8M +17.39% | |
Operating Profit | -37.1M -14.20% | -43.2M -10.17% | -48.1M -34.24% | -73.2M +12.79% | |
Interest Income | 1.0M -58.95% | 2.5M -35.14% | 3.8M +404.86% | 761,000 +4,127.78% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 1.0M -58.95% | 2.5M -35.14% | 3.8M +404.86% | 761,000 +4,127.78% | |
Total Nonoperating Income and Expense | -337,000 -2,908.33% | 12,000 -65.71% | 35,000 +168.63% | -51,000 +5,000.00% | |
Income before Taxes | -35.6M -12.64% | -40.7M -7.95% | -44.2M -39.54% | -73.2M +12.82% | |
Income Taxes | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -35.6M -12.64% | -40.7M -7.95% | -44.2M -39.54% | -73.2M +12.82% | |
Net Income from Continuing Operations Applicable to Common | -35.6M -12.64% | -40.7M -7.95% | -44.2M -39.54% | -73.2M +12.82% | |
Basic EPS and Net Income | -0.43 -23.21% | -0.56 -9.68% | -0.62 -40.38% | -1.04 -94.08% | |
Diluted EPS and Net Income | -0.43 -23.21% | -0.56 -9.68% | -0.62 -40.38% | -1.04 -94.08% | |
Basic Weighted Average Shares | 81.8M +12.96% | 72.4M +1.54% | 71.3M +1.23% | 70.4M +1,808.92% | |
Diluted Weighted Average Shares | 81.8M +12.96% | 72.4M +1.54% | 71.3M +1.23% | 70.4M +1,808.92% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 35.1M -6.80% | 37.6M -49.93% | 75.2M -36.00% | 117.5M -37.68% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 35.1M -6.80% | 37.6M -49.93% | 75.2M -36.00% | 117.5M -37.68% | |
Total Current Assets | 50.9M -5.22% | 53.7M -39.59% | 88.9M -30.90% | 128.7M -34.85% | |
Accumulated Depreciation | 4.4M +24.94% | 3.6M +17.05% | 3.0M +30.88% | 2.3M +64.68% | |
Property and Plant and Equipment and Net | 2.5M -18.35% | 3.1M +4.10% | 3.0M -7.67% | 3.2M -13.46% | |
Total Long-Term Assets | 1.8M -12.81% | 2.1M -9.73% | 2.3M +7.15% | 2.1M +73.20% | |
Total Assets | 55.3M -6.18% | 58.9M -37.47% | 94.2M -29.73% | 134.1M -33.79% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | 2.0M 0.00% | |
Total Current Liabilities | 11.7M +34.40% | 8.7M -0.44% | 8.8M -0.40% | 8.8M -44.06% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 66,000 -15.38% | 78,000 +21.88% | 64,000 -95.81% | 1.5M +121.80% | |
Total Liabilities | 14.3M +44.58% | 9.9M +0.62% | 9.8M -5.12% | 10.3M -36.42% | |
Retained Earnings | -330.0M +12.08% | -294.4M +16.05% | -253.7M +21.12% | -209.5M +53.67% | |
Total Stockholders Equity | 41.0M -16.38% | 49.0M -41.90% | 84.4M -31.78% | 123.7M -33.56% | |
Total Shares Outstanding | 82.2M +12.35% | 73.1M +1.72% | 71.9M +1.72% | 70.7M +0.49% | |
Cash Flow | |||||
Cash from Operating Activities | -27.9M -27.91% | -38.8M -7.28% | -41.8M -42.20% | -72.3M +53.32% | |
Capital Expenditures | 1.2M +209.40% | 383,000 -52.36% | 804,000 +37.44% | 585,000 -78.42% | |
Cash from Investing Activities | -1.2M +209.40% | -383,000 -52.36% | -804,000 +37.44% | -585,000 -78.42% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 27.5M +2,598.92% | 1.0M +485.63% | 174,000 +2,385.71% | 7,000 -100.00% | |
Financials Ratio | |||||
Gross Margin | 49.51% +8.33% | 45.70% +5.99% | 43.12% N/A | N/A N/A | |
Operating Margin | -325.36% -2.97% | -335.33% -23.11% | -436.14% N/A | N/A N/A | |
Return on Assets | -62.32% +17.16% | -53.19% +37.23% | -38.76% -10.85% | -43.48% N/A | |
Return on Equity | -79.01% +29.46% | -61.03% +43.56% | -42.51% -9.95% | -47.21% N/A | |
Revenue Growth | -11.57% -168.73% | 16.84% N/A | N/A N/A | N/A N/A | |
Current Ratio | 4.34 -29.48% | 6.15 -39.32% | 10.14 -30.62% | 14.62 N/A | |
Cash Ratio | 2.99 -30.66% | 4.31 -49.71% | 8.57 -35.74% | 13.34 N/A | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow